AQR Capital Management »

Conduit Pharmaceuticals shares owned by AQR Capital Management

Quarter-by-quarter ownership of Conduit Pharmaceuticals (CDT) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Conduit Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Conduit Pharmaceuticals held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conduit Pharmaceuticals by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.9k 33k 0.12

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ge Aerospace Com New (GE)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Zoom Video Communications In Cl A (ZM)
Cigna Corp (CI)
At&t (T)
Progressive Corporation (PGR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for AQR Capital Management

Top funds holding Conduit Pharmaceuticals

Barclays
BlackRock
BlackRock
Geode Capital Management
Vanguard Group
Citadel Advisors
Northern Trust
New York State Common Retirement Fund
State Street Corporation
Morgan Stanley
Charles Schwab Investment Management
Bridgeway Capital Management
JustInvest
SG Americas Securities
AQR Capital Management

View all funds holding Conduit Pharmaceuticals